Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Association of Genetic Ancestry With DNA Methylation Changes in Prostate Cancer Disparity.

Apprey V, Wang S, Tang W, Kittles RA, Southerland WM, Ittmann M, Kwabi-Addo B.

Anticancer Res. 2019 Nov;39(11):5861-5866. doi: 10.21873/anticanres.13790.

PMID:
31704810
2.

Correlating blood-based DNA methylation markers and prostate cancer risk in African-American men.

Moses-Fynn E, Tang W, Beyene D, Apprey V, Copeland R, Kanaan Y, Kwabi-Addo B.

PLoS One. 2018 Sep 11;13(9):e0203322. doi: 10.1371/journal.pone.0203322. eCollection 2018.

3.

Sex steroid-induced DNA methylation changes and inflammation response in prostate cancer.

Wang S, Clarke PAG, Davis R, Mumuni S, Kwabi-Addo B.

Cytokine. 2016 Oct;86:110-118. doi: 10.1016/j.cyto.2016.07.006. Epub 2016 Aug 5.

PMID:
27500645
4.

Design, synthesis and cytotoxicity studies of dithiocarbamate ester derivatives of emetine in prostate cancer cell lines.

Akinboye ES, Bamji ZD, Kwabi-Addo B, Ejeh D, Copeland RL, Denmeade SR, Bakare O.

Bioorg Med Chem. 2015 Sep 1;23(17):5839-45. doi: 10.1016/j.bmc.2015.06.072. Epub 2015 Jul 4.

5.

Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.

Devaney JM, Wang S, Furbert-Harris P, Apprey V, Ittmann M, Wang BD, Olender J, Lee NH, Kwabi-Addo B.

Epigenetics. 2015;10(4):319-28. doi: 10.1080/15592294.2015.1022019. Epub 2015 Apr 11.

6.

DNA methylation profile associated with rapid decline in kidney function: findings from the CRIC study.

Wing MR, Devaney JM, Joffe MM, Xie D, Feldman HI, Dominic EA, Guzman NJ, Ramezani A, Susztak K, Herman JG, Cope L, Harmon B, Kwabi-Addo B, Gordish-Dressman H, Go AS, He J, Lash JP, Kusek JW, Raj DS; Chronic Renal Insufficiency Cohort (CRIC) Study.

Nephrol Dial Transplant. 2014 Apr;29(4):864-72. doi: 10.1093/ndt/gft537. Epub 2014 Feb 9.

7.

Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.

Devaney JM, Wang S, Funda S, Long J, Taghipour DJ, Tbaishat R, Furbert-Harris P, Ittmann M, Kwabi-Addo B.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):292-300. doi: 10.1038/pcan.2013.21. Epub 2013 Jul 30.

PMID:
23896626
8.

Design, synthesis, and evaluation of pH-dependent hydrolyzable emetine analogues as treatment for prostate cancer.

Akinboye ES, Rosen MD, Denmeade SR, Kwabi-Addo B, Bakare O.

J Med Chem. 2012 Sep 13;55(17):7450-9. doi: 10.1021/jm300426q. Epub 2012 Aug 16.

9.

Relationship between tumor DNA methylation status and patient characteristics in African-American and European-American women with breast cancer.

Wang S, Dorsey TH, Terunuma A, Kittles RA, Ambs S, Kwabi-Addo B.

PLoS One. 2012;7(5):e37928. doi: 10.1371/journal.pone.0037928. Epub 2012 May 31.

10.

Humanizing π-class glutathione S-transferase regulation in a mouse model alters liver toxicity in response to acetaminophen overdose.

Vaughn MP, Biswal Shinohara D, Castagna N, Hicks JL, Netto G, De Marzo AM, Speed TJ, Reichert ZR, Kwabi-Addo B, Henderson CJ, Wolf CR, Yegnasubramanian S, Nelson WG.

PLoS One. 2011;6(10):e25707. doi: 10.1371/journal.pone.0025707. Epub 2011 Oct 11.

11.

Transcriptional and post-transcriptional regulation of Sprouty1, a receptor tyrosine kinase inhibitor in prostate cancer.

Darimipourain M, Wang S, Ittmann M, Kwabi-Addo B.

Prostate Cancer Prostatic Dis. 2011 Dec;14(4):279-85. doi: 10.1038/pcan.2011.33. Epub 2011 Aug 9.

PMID:
21826097
12.

Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.

Kwabi-Addo B, Wang S, Chung W, Jelinek J, Patierno SR, Wang BD, Andrawis R, Lee NH, Apprey V, Issa JP, Ittmann M.

Clin Cancer Res. 2010 Jul 15;16(14):3539-47. doi: 10.1158/1078-0432.CCR-09-3342. Epub 2010 Jul 6.

13.

DNA methylation and aberrant expression of Sprouty1 in human prostate cancer.

Kwabi-Addo B, Ren C, Ittmann M.

Epigenetics. 2009 Jan;4(1):54-61. Epub 2009 Jan 20.

PMID:
19164898
14.

Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.

Kondo Y, Shen L, Cheng AS, Ahmed S, Boumber Y, Charo C, Yamochi T, Urano T, Furukawa K, Kwabi-Addo B, Gold DL, Sekido Y, Huang TH, Issa JP.

Nat Genet. 2008 Jun;40(6):741-50. doi: 10.1038/ng.159. Epub 2008 May 18.

PMID:
18488029
15.

Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.

Chung W, Kwabi-Addo B, Ittmann M, Jelinek J, Shen L, Yu Y, Issa JP.

PLoS One. 2008 Apr 30;3(4):e2079. doi: 10.1371/journal.pone.0002079. Erratum in: PLoS ONE. 2008;3(5). doi: 10.1371/annotation/2548989f-1f13-4ea5-8af8-62420b0a590e.

16.

Age-related DNA methylation changes in normal human prostate tissues.

Kwabi-Addo B, Chung W, Shen L, Ittmann M, Wheeler T, Jelinek J, Issa JP.

Clin Cancer Res. 2007 Jul 1;13(13):3796-802.

17.

Relaxin promotes prostate cancer progression.

Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI.

Clin Cancer Res. 2007 Mar 15;13(6):1695-702.

18.

Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer.

Wang J, Thompson B, Ren C, Ittmann M, Kwabi-Addo B.

Prostate. 2006 May 1;66(6):613-24.

PMID:
16388505
19.

Allele-specific methylation of a functional CTCF binding site upstream of MEG3 in the human imprinted domain of 14q32.

Rosa AL, Wu YQ, Kwabi-Addo B, Coveler KJ, Reid Sutton V, Shaffer LG.

Chromosome Res. 2005;13(8):809-18. Epub 2005 Dec 8.

PMID:
16331412
20.

The role of fibroblast growth factors and their receptors in prostate cancer.

Kwabi-Addo B, Ozen M, Ittmann M.

Endocr Relat Cancer. 2004 Dec;11(4):709-24. Review.

PMID:
15613447
21.

The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer.

Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M.

Cancer Res. 2004 Jul 15;64(14):4728-35.

22.

FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.

Polnaszek N, Kwabi-Addo B, Wang J, Ittmann M.

Prostate. 2004 Jun 15;60(1):18-24.

PMID:
15129425
23.

Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer.

Polnaszek N, Kwabi-Addo B, Peterson LE, Ozen M, Greenberg NM, Ortega S, Basilico C, Ittmann M.

Cancer Res. 2003 Sep 15;63(18):5754-60.

24.

Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.

Lu S, Chen GL, Ren C, Kwabi-Addo B, Epner DE.

Biochem Pharmacol. 2003 Sep 1;66(5):791-800.

PMID:
12948860
25.

Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression.

Kwabi-Addo B, Giri D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11563-8. Epub 2001 Sep 11.

26.

Alternative splicing of fibroblast growth factor receptors in human prostate cancer.

Kwabi-Addo B, Ropiquet F, Giri D, Ittmann M.

Prostate. 2001 Feb 1;46(2):163-72.

PMID:
11170144
27.

FGF-10 is expressed at low levels in the human prostate.

Ropiquet F, Giri D, Kwabi-Addo B, Schmidt K, Ittmann M.

Prostate. 2000 Sep 1;44(4):334-8.

PMID:
10951499
28.

Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer.

Ropiquet F, Giri D, Kwabi-Addo B, Mansukhani A, Ittmann M.

Cancer Res. 2000 Aug 1;60(15):4245-50.

29.

Absence of PTEN/MMAC1 pseudogene in mice.

Kwabi-Addo B, Thompson TC, Ittmann M.

DNA Cell Biol. 2000 May;19(5):301-5.

PMID:
10855797
30.

A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination.

Smith AJ, De Sousa MA, Kwabi-Addo B, Heppell-Parton A, Impey H, Rabbitts P.

Nat Genet. 1995 Apr;9(4):376-85. Erratum in: Nat Genet 1996 Jan;12(1):110.

PMID:
7795643

Supplemental Content

Loading ...
Support Center